Habip ALMİS, Mehmet TEKİN, Ibrahim Hakan BUCAK, Mehmet GEYİK, Fedli Emre KİLİÇ, Davut KAYAK, Mehmet TURGUT, Capan KONCA

The evaluation of chickenpox in the post-vaccination period in Turkey

Aim: Chickenpox is a viral infectious disease capable of causing severe morbidity, and even mortality. The purpose of this studywas to determine the current position and demographic characteristics of cases of chickenpox following the addition of chickenpoxvaccination to the routine vaccine schedule in Turkey.Mateial and Methods: Patients aged 0-17 years presented to Adiyaman University Training and Research Hospital Pediatrics clinicsand diagnosed with chickenpox between January 2013 and December 2016 were included in the study. Data were analyzed onStatistical Package for the Social Sciences (SPSS, version 22.0, Chicago, IL, USA) software. p

PDF

___

1. Heininger U, Seward JF. Varicella. Lancet 2006;368:1365- 76.
2. Drwal-Klein LA, O’Donovan CA. Varicella in pediatric patients. Ann Pharmacother 1993;27:938-49.
3. Kurugol Z, Halicioglu O, Koc F, et al. Varicella rates among unvaccinated and one-dose vaccinated healthy children in İzmir, Turkey. Int J Infect Dis 2011;15:e475-80.
4. Kilic A, Unuvar E, Yilmaz C, et al. The effectiveness of varicella vaccination during an outbreak in a children’s daycare center. Vaccine 2008;26:3371-2.
5. WHO Report. Varicella and herpes zoster vaccines: WHO position paper, June 2014-Recommendations. Vaccine 2016;34:198-9.
6. Marin M, Güris D, Chaves SS, et al. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007;56:1-40.
7. Helmuth IG, Poulsen A, Suppli CH, et al. Varicella in Europe-A review of the epidemiology and experience with vaccination. Vaccine 2015;33:2406-13.
8. Seward JF, Marin M, Vâzquez M. Varicella vaccine effectiveness in the US vaccination Schedule: a review. J Infect Dis 2008;197:S82-9.
9. Miron D, Lavi I, Kitov R, et al. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J 2005;24:233-6.
10. Sheffer R, Segal D, Rahamani S, et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 2005;24:434-7.
11. Passwell JH, Hemo B, Levi Y, Ramon R, Friedman N, Lerner- Geva L. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J 2004;23:221-6.
12. Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubellavaricella combination vaccine and the risk of febrile seizures. Pediatrics 2010;126:e1-8.
13. Macartney KK, Gidding HF, Trinh L, et al. Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine 2015;33:1412-7.
14. Ma SJ, Xiong YQ, Jiang LN, et al. Risk of febrile seizure after measles-mumps- rubella-varicella vaccine: A systematic review and meta-analysis. Vaccine 2015;33:3636-49.
15. Dinleyici EC, Kurugol Z, Turel O, et al. The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study). Eur J Pediatr 2012;171:817-25.
16. Uygur Külcü N, Say A, Güven F, et al. The evaluation of hospitalized children with varicella and its complications in a training hospital. J Pediatr Inf 2012;6:12-7.
17. Guzman Laura KP, Perianez Vasco A, Falcon Neyra MD, Croche Santander B. Hospital admissions due to varicella in a tertiary hospital. An Pediatr (Barc) 2014;80:399-403.
18. Ziebold C, von Kries R, Lang R, et al. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 2001;108:e79.
19. Theodoridou M, Laina I, Hadjichristodoulou C, et al. Varicella-related complications and hospitalisations in tertiary pediatric medical centre before vaccine introduction. Eur J Pediatr 2006;165:273-4.